Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: ‘a call for cardiovascular prevention’-Reference-Cited by-同舟云学术

Pilot study of coronary atherosclerotic risk and plaque burden in HIV patients: ‘a call for cardiovascular prevention’

Published:2002-08 Issue:2 Volume:163 Page:349-354
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Acevedo Monica,Sprecher Dennis L.,Calabrese Leonard,Pearce Gregory L.,Coyner Denise L.,Halliburton Sandra S.,White Richard D.,Sykora Elizabeth,Kondos George T.,Hoff Julie A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference31 articles.

1. Epidemiological and clinical aspects of the metabolic complications of HIV infection the fat redistribution syndrome [editorial];Wanke;AIDS,1999

2. Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance;Carr;Lancet,1998

3. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study;Carr;Lancet,1999

4. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The swiss HIV cohort study;Periard;Circulation,1999

5. Severe premature coronary artery disease with protease inhibitors [letter; see comments];Henry;Lancet,1998

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Coronary Artery Calcification and Plaque Characteristics in People Living With HIV: A Systematic Review and Meta‐Analysis;Journal of the American Heart Association;2021-10-05

2. Coronary Artery Disease in HIV-Infected Patients: Downside of Living Longer;Current Atherosclerosis Reports;2017-03-06

3. Inflammatory Markers Associated With Subclinical Coronary Artery Disease: The Multicenter AIDS Cohort Study;Journal of the American Heart Association;2016-06-13

4. Pharmacokinetic, Pharmacogenetic, and Other Factors Influencing CNS Penetration of Antiretrovirals;AIDS Research and Treatment;2016

5. Lipoprotein-Associated Phospholipase A2, a Novel Cardiovascular Inflammatory Marker, in HIV-Infected Patients;Clinical Infectious Diseases;2013-12-11